CIK 1277890
NANO CAP NEW MILLENNIUM GROWTH FUND L P
Institutional 13F holdings & portfolio
Holdings
170
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
1
Holdings
13F filings as of Dec 31, 2025 · Showing 101–150 of 170
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| ATHM | Autohome Inc. | 14K | $100K–$500K | SH |
| TMO | Thermo Fisher Scientific Inc. | 510 | $100K–$500K | SH |
| CAVA | CAVA Group, Inc. | 5K | $100K–$500K | SH |
| SPRY | ARS Pharmaceuticals Inc. | 25K | $100K–$500K | SH |
| PLRX | Pliant Therapeutics | 235K | $100K–$500K | SH |
| PXLW | Pixelworks, inc. | 44K | $100K–$500K | SH |
| PRNT | 3D Printing ETF | 13K | $100K–$500K | SH |
| NKTX | Nkarta, Inc. | 150K | $100K–$500K | SH |
| EEM | iShares MSCI Emerging Markets ETF | 5K | $100K–$500K | SH |
| GDX | VanEck Vectors Gold Miners ETF | 3K | $100K–$500K | SH |
| SSTK | Shutterstock Inc. | 13K | $100K–$500K | SH |
| BRKR | Bruker Corporation | 5K | $100K–$500K | SH |
| MBLY | Mobileye Global Inc. | 23K | $100K–$500K | SH |
| IBTA | Ibotta, Inc. | 10K | $100K–$500K | SH |
| AUTL | Autolus Therapeutics PLC | 113K | $100K–$500K | SH |
| XTNT | Xtant Medical Holdings Inc. | 280K | $100K–$500K | SH |
| SNOW | Snowflake Inc. | 1K | $100K–$500K | SH |
| SBUX | Starbucks Corporation | 3K | $100K–$500K | SH |
| BWAY | Brainsway Ltd. | 11K | $100K–$500K | SH |
| LUNG | Pulmonx Corporation | 85K | $100K–$500K | SH |
| TARA | Protara Therapeutics | 35K | $100K–$500K | SH |
| DXR | Daxor Corporation | 13K | $100K–$500K | SH |
| IMA | ImageneBio Inc. | 27K | $100K–$500K | SH |
| CRBU | Caribou Biosciences | 113K | $100K–$500K | SH |
| AVIR | Atea Pharmaceuticals, Inc. | 50K | $100K–$500K | SH |
| LYB | LyondellBasell Industries NV | 4K | $100K–$500K | SH |
| DDOG | Datadog Inc. | 1K | $100K–$500K | SH |
| DNA | Ginkgo Bioworks Holdings, Inc. | 20K | $100K–$500K | SH |
| ENPH | Enphase Energy Inc. | 5K | $100K–$500K | SH |
| — | Ceragon Networks Ltd | 75K | $100K–$500K | SH |
| KZR | Kezar Life Sciences | 25K | $100K–$500K | SH |
| DJP | iPath Bloomberg Commodity Index Total Return ETN | 4K | $100K–$500K | SH |
| — | S4 Capital PLC | 575K | $100K–$500K | SH |
| ACCS | ACCESS Newswire | 15K | $100K–$500K | SH |
| PHVS | Pharvaris B.V. | 5K | $100K–$500K | SH |
| — | Neo Performance Materials Inc. | 12K | $100K–$500K | SH |
| BZUN | Baozun Inc. | 50K | $100K–$500K | SH |
| MRNA | Moderna, Inc. | 5K | $100K–$500K | SH |
| BE | Bloom Energy Corporation | 2K | $100K–$500K | SH |
| ORIC | ORIC Pharmaceuticals | 15K | $100K–$500K | SH |
| PASG | Passage Bio Inc. | 10K | $100K–$500K | SH |
| DV | DoubleVerify Holdings Inc. | 10K | $100K–$500K | SH |
| NTLA | Intellia Therapeutics | 13K | $100K–$500K | SH |
| BOLT | Bolt Biotherapeutics | 21K | $100K–$500K | SH |
| OPRA | Opera Ltd | 8K | $100K–$500K | SH |
| CGEM | Cullinan Oncology | 10K | $100K–$500K | SH |
| LXFR | Luxfer Holdings PLC | 8K | $100K–$500K | SH |
| FIG | Figma, Inc. | 3K | $50K–$100K | SH |
| HAP | VanEck Vectors Natural Resources ETF | 2K | $50K–$100K | SH |
| WPM | Wheaton Precious Metals Corp. | 750 | $50K–$100K | SH |